Advanced company searchLink opens in new window

CANADIAN PHARMA CAPITAL LIMITED

Company number 12736213

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Mar 2021 GAZ2(A) Final Gazette dissolved via voluntary strike-off
12 Jan 2021 GAZ1(A) First Gazette notice for voluntary strike-off
05 Jan 2021 DS01 Application to strike the company off the register
23 Nov 2020 PSC01 Notification of Michael Stephen Johnson as a person with significant control on 21 November 2020
23 Nov 2020 PSC07 Cessation of Tamer Mohammed Soliman as a person with significant control on 21 November 2020
23 Nov 2020 CH01 Director's details changed for Professor Michael Stephen Johnson on 23 November 2020
21 Nov 2020 AP01 Appointment of Professor Michael Stephen Johnson as a director on 21 November 2020
21 Nov 2020 SH01 Statement of capital following an allotment of shares on 21 November 2020
  • GBP 300
09 Nov 2020 TM01 Termination of appointment of Guy Rothschild as a director on 5 November 2020
12 Aug 2020 TM01 Termination of appointment of Tamer Mohammed Soliman as a director on 12 August 2020
11 Aug 2020 AP01 Appointment of Mr Guy Rothschild as a director on 10 August 2020
28 Jul 2020 AP01 Appointment of Mr Dominic Traynor as a director on 28 July 2020
13 Jul 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-07-13
  • GBP 30